AI MARKET SCANNING

Viridian Therapeutics Inc

📅 Next Catalyst: Nov 04, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +1.44%
MAX GAP RECORD +35.63%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $VRDN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
-0.64%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+35.63%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
-6.53%
Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN)
+3.15%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
+1.72%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-1.37%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
-0.52%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.5%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $VRDN

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 138m +3.63%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗